Oyebimpe Olayinka-Amao
Overview
Explore the profile of Oyebimpe Olayinka-Amao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barrett A, Olayinka-Amao O, Ziemssen T, Bharadia T, Henke C, Kamudoni P
Neurodegener Dis Manag
. 2025 Jan;
:1-8.
PMID: 39849902
No abstract available.
2.
Barrett A, Olayinka-Amao O, Martin S, Doshi D, Bishop K, Youakim J
Clin Ther
. 2025 Jan;
47(3):181-188.
PMID: 39824747
Purpose: Rett syndrome (RTT) is a rare neurodevelopmental disorder that mainly affects girls and women. Trofinetide is approved for the treatment of RTT in adults and children aged ≥2 years....
3.
Kamudoni P, Amtmann D, Johns J, Cook K, Salem R, Salek S, et al.
Neurodegener Dis Manag
. 2024 Jul;
14(5):119-125.
PMID: 39054910
What Is This Summary About?: This summary describes how researchers worked with people with multiple sclerosis (MS), neurologists and measurement experts to create an easy-to-use questionnaire to measure the physical...
4.
Barrett A, Olayinka-Amao O, Ziemssen T, Bharadia T, Henke C, Kamudoni P
Neurol Ther
. 2024 Feb;
13(2):449-464.
PMID: 38345742
Introduction: Multiple sclerosis (MS) is a disabling disease with unpredictable clinical manifestations. As clinical assessments may not fully capture the impact of MS on quality of life, they can be...
5.
Browning J, Cartwright M, Thorla Jr I, Martin S, Olayinka-Amao O, Maeda-Chubachi T
Am J Clin Dermatol
. 2022 Oct;
24(1):119-133.
PMID: 36287306
Background: Molluscum contagiosum is often characterized by persistent lesions and bothersome symptomology. What patients with molluscum contagiosum and/or caregivers consider to be meaningful measures of therapeutic success is unknown. Objective:...
6.
Martin S, Sanchez R, Olayinka-Amao O, Harris C, Fehnel S
J Patient Rep Outcomes
. 2022 Jul;
6(1):84.
PMID: 35904713
Background: New treatments are being evaluated for lipodystrophy; however, limited information is available on the patient experience. Results of a prior patient panel showed that hunger and temperature-related symptoms were...
7.
Kamudoni P, Amtmann D, Johns J, Cook K, Salem R, Salek S, et al.
Mult Scler Relat Disord
. 2022 May;
62:103753.
PMID: 35598408
Background: A valid, sensitive patient-reported outcome (PRO) measure of physical function (PF) for people with multiple sclerosis (MS) would have substantial value in routine care and clinical research. We now...
8.
Clark M, Romano C, Olayinka-Amao O, Whalley D, Crawford R, Pathak P, et al.
J Patient Rep Outcomes
. 2022 Mar;
6(1):25.
PMID: 35306621
Background: Childhood asthma is an important unmet need. To date, patient-reported outcome measures (PROMs) for children with asthma have used a combination of caregiver or proxy-reported and self-reported measures. No...
9.
Nag A, Martin S, Mladsi D, Olayinka-Amao O, Purser M, Vekaria R
Clin Exp Gastroenterol
. 2020 Aug;
13:255-265.
PMID: 32765039
Background: Chronic idiopathic constipation (CIC) is a functional gastrointestinal disorder with an estimated prevalence of 16% in the USA; however, the humanistic and economic burden of CIC is poorly characterized....
10.
Taylor P, Betteridge N, Brown T, Woolcott J, Kivitz A, Zerbini C, et al.
Patient Prefer Adherence
. 2020 Feb;
14:119-131.
PMID: 32021123
Purpose: Current knowledge of the reasons for patients' preference for rheumatoid arthritis (RA) treatment modes is limited. This study was designed to identify preferences for four treatment modes, and to...